Legal updates and opinions
News / News
Compensation for employees who experience injuries, illness or death as a result of the Covid-19 vaccine
Compensation for Occupational Injuries and Diseases Act 130 of 1993
by Jacques van Wyk, Director and Andre van Heerden, Senior Associate
On 22 October 2021, a notice was published in the Government Gazette in terms of section 6A(b) of the Compensation for Occupational Injuries and Diseases Act 130 of 1993 (“COIDA“). The notice relates to the compensation for side effects to the Covid-19 vaccination (“Notice“) based on employees who experience injuries, illness or death as a result of the Covid-19 vaccine in the circumstances where the requirement to have the vaccine is an inherent requirement of the employee’s job or where the employee is required to do so in terms of his/her employer’s risk assessment.
Read our article discussing vaccination policies for the workplace for more on the implementation of a mandatory vaccination policy and the required risk assessment).
The Notice provides that if an employee is required to receive a Covid-19 vaccine, either as a result of an occupational health and safety risk assessment conducted by an employer or where the vaccine is an inherent requirement of employment, any injury, illness or death incurred as a result will be covered by the Compensation Fund.
However, in order for such cover to extend to an employee, there are 6 requirements that apply:
- The vaccine must be regarded as an inherent requirement of employment in terms of the employer’s risk assessment;
- The employee must have received a SAHPRA-approved Covid-19 vaccine;
- Evidence of the employer’s risk assessment and vaccination plan in terms of the Consolidated Directions on Occupational Health and Safety Measures in Certain Workplaces must be provided;
- The chronological sequence between the vaccine inoculation and the development of the employee’s symptoms and clinical signs must be provided;
- The employee must have presented with symptoms and clinical signs that are generally recognised as side effects of the Covid-19 vaccine; and
- Additional tests may be required to assess the presence of abnormalities of any organ affected.
A copy of the Notice can be accessed here.
Latest News
Topic – Part 3: The Cutting Red Tape Project
Proposed amendments to the JSE Listings Requirements On 5 March 2021, the Issuer Regulation Division of the JSE issued a [...]
Section 150A LRA intervention in the Sibanye-Stillwater deadlock?
After a lengthy period of striking - nearly 3 (three) months - over wage increases at Sibanye's gold operations, the [...]
Technology, Media and Telecommunications Africa Quarterly e‑Bulletin | May 2022
Botswana Broadband Facts and Figures Report, 2021 On 21 January 2022, the Botswana Communications Regulatory Authority (BOCRA) published its Broadband [...]
A new reality for illegal miners and the ‘zama zamas’?
Illegal mining challenge Illegal mining is a critical challenge in the South African mining and minerals industry. In response to [...]
Treaty residence of mobile South Africans – An interesting UK tax case
Treaty residence of mobile South Africans The tax residence status of a natural person with a mobile lifestyle recently formed [...]
The case for South Africa’s business rescue procedure – Commissioner of Sars v Louis Pasteur Investments (Pty) Ltd and others
South Africa's business rescue procedure by Eric Levenstein, Head of Insolvency, Business Rescue & Restructuring and, Brandon Starr, Candidate Attorney [...]
